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Gap junctions provide coupled cells with a direct pathway for sharing ions, nutrients, and small metabolites, thus helping to maintain
homeostasis in various tissues. Abnormal function and/or expression of specific connexin genes has been linked to several diseases, including
genetic deafness, skin disease, peripheral neuropathies, and cataracts. Research has provided significant insight into the function of gap
junction proteins in both in vitro and in vivo models; however, questions regarding the exact mechanisms by which connexin related diseases
occur in mammalian systems remain. Here, we discuss the disease states that are related to three human connexin genes, Cx26 (GJB2), Cx46
(GJA3) and Cx50 (GJA8), and recent scientific evidence characterizing those diseases in various experimental models.
D 2004 Elsevier B.V. All rights reserved.Keywords: Connexin; Ear; Skin; Lens1. Introduction
Multicellular organisms require various means of cel-
lular communication to respond to internal and environ-
mental stimuli. One method of communication is through
the use of gap junctions, which allow the exchange of
ions, nutrients and small metabolites from one cell to
neighboring cells. Gap junctions are composed of oligo-
meric structures known as connexons, which are in turn
formed from a large family of protein subunits called
connexins. A connexon forms when six connexins oligo-
merize within the plasma membrane to complete one half
of a gap junction channel. A fully functional gap junction
channel is produced when two connexons from adjacent
cells align in the extracellular space to allow direct
communication between the two cells. Gap junction
channels vary in complexity depending on the composi-
tion of connexin subunits within the channel. Homomeric
connexons are formed when the hemichannel is composed
of a single type of connexin, whereas heteromeric con-
nexons contain different connexins. The arrangement of
the complete gap junction channel amplifies this structural
diversity, as it may be composed of connexons made0005-2736/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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posed of identical connexons, whereas heterotypic chan-
nels are composed of different connexons. The variations
in the structural alignment of gap junction proteins allow
for a vast array of possibilities for sharing metabolites and
ions between coupled cells. Connexins are found through-
out the vertebrate phyla, but nematodes and arthropods
lack connexins and use an unrelated family of gap
junction proteins known as innexins [66]. Although these
gene families are different, and innexins are beyond the
scope of this review, the invertebrate channels show
obvious similarities in molecular and functional diversity
as the vertebrate connexins [67,93].2. Human connexin genes
In humans there are at least 20 connexin genes that
exhibit complex and overlapping patterns of expression
[102]. Comparison of connexin sequences has provided
some insights into the evolution of connexin genes and
suggests that they may have originated from a common
ancestor and subsequently divided into several subgroups
(Fig. 1). To root our phylogenetic tree, we have included
a recently identified invertebrate chordate connexin, Ciona
intestinalis Cx36.9 (T.W. White and P.R. Brink unpub-
lished data, GenBank accession number BK001247; see
also Ref. [82]). This tunicate connexin does not cluster
Fig. 1. Phylogenetic tree of chordate connexin genes. Human connexin
genes were aligned according to their nucleotide sequence and compared to
a more primitive tunicate gene that encodes for a gap junction protein. The
human genes were segregated into three groups,h, a, and a third unnamed
group. Connexin genes in the h group encoded gap junctions no more than
32 kDa in molecular weight, whereas the a group encoded connexins
greater than or equal to 37 kDa. Older human connexin genes were aligned
with the more primitive connexin from C. intestinalis (Cx36.9), suggesting
a later evolutionary split between the a and h groups.
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to reexamine the sequence relationships between verte-
brate connexins. The human connexin genes are com-
monly divided into a, h, and an unnamed third group, all
of which encode for gap junction channels of different
molecular weights [101]. Examination of these groups
shows an apparent separation of channels that is partially
dependant on the molecular weight of each individual gap
junction protein. In general, connexin genes within the h
group encode proteins smaller than 32 kDa, whereas the
a genes encode connexins larger than 37 kDa. While
these divisions are true for many of the connexin genes,
there are at least seven connexins of intermediate molec-
ular weight (31–47 kDa) that violate this dichotomy.
Interestingly, many of these outliers show a closer se-
quence relationship with Ciona Cx36.9 than the a or h
branches. Consistent with this view, two connexins from
this third group also have introns within their coding
regions (Cx36 and Cx40.1), a feature shared by the more
ancient tunicate connexin. Taken together, these sequence
relationships suggest that the a–h split was a more recent
evolutionary event within the vertebrate connexin family
and that the third outlying group may contain the more
primitive genes.3. Connexin mutations in human disease
Cellular communication is an important aspect in main-
taining homeostasis within multicellular organisms. Pro-
cesses such as hormone signaling, neural transmission, and
cell-to-cell adhesion have provided animals with a wide
variety of communication mechanisms that operate with
very high specificity. In addition to these mechanisms of
cellular communication, individual cells also contain nu-
merous protein channels that allow communication with
the extracellular environment. In fact, membrane proteins
have the ability to pass a large number of ions and
metabolites across the cell membrane in very short time
periods. With such numerous possibilities of cellular
communication, it may appear that the direct connection
between the intracellular environments of two adjacent
cells provided by gap junctions would be redundant. In
contrast to this view, recent evidence has shown that
mutations within several connexins give rise to various
hereditary diseases in humans [22,99,102]. Currently, at
least eight connexin genes have been implicated in hered-
itary human diseases (Table 1). For example, Charcot–
Marie–Tooth disease is caused by mutations in the Cx32
gene [4], whereas erythrokeratodermia variabilis can result
from mutations in either Cx31 or Cx30.3 [51,74]. In
addition to these disorders, connexin mutations are also
involved in deafness, cataracts, and numerous skin dis-
eases. While research has provided some insight as to how
mutations within these genes affect humans, the generation
of suitable animal models for studying connexin related
diseases has proven to be challenging in some cases. Here
we discuss several diseases that are known to arise from
mutations in connexins 26, 46, and 50, and research that
further characterizes these mutations/deletions and their
relation to connexin function. Although the focus of this
review is limited to these three genes, the general princi-
ples discussed apply to other connexin disorders. One
such principle is the apparent lack of redundancy that is
evident in connexin disorders where more than one con-
nexin gene is expressed in a particular tissue. The inability
of other connexins to compensate for loss of function in a
mutant connexin is a prevalent feature in connexin-related
disorders, and may represent strict requirements between
tissue homeostasis and gap junction-mediated cellular
communication.4. Mutations in Cx26 cause deafness
Genetic deafness has been extensively studied by a
number of laboratories, and the data concerning both
syndromic and nonsyndromic forms of genetic deafness
clearly point to mutations within the Cx26 gene as a
causative factor in the onset of hearing loss. Initially, the
Cx26 gene was implicated in autosomal recessive forms of
deafness, but was later found to be involved in both
Table 1
Summary of Cx genes, human diseases, and knockout mouse phenotypes
Gene Expression
patterns
Human hereditary
diseases
KO mouse
phenotypes
OMIM
reference
GJB7 (Cx25) unknown unknown unknown no reference
GJB2 (Cx26) cochlea, skin, liver,
placenta, breast
Deafness, DFNB1 Embryonic lethal 220290
Deafness, DFNA3 601544
Deafness with
keratopachydermia
Conditional KO 124500
Keratitis-ichthyosis-deafness
syndrome
hearing impairment 148210
Ichthyosis, with deafness 602540
GJB6 (Cx30) cochlea, skin, brain Deafness, DFNB1
Deafness, DFNA3
hearing impairment 220290
601544
GJB4 (Cx30.3) skin erythrokeratodermia variabilis unknown 133200
GJB3 (Cx31) skin, placenta Deafness, DFNA2 placental 600101
erythrokeratodermia variabilis dysmorphogenesis 133200
GJB5 (Cx31.1) skin unknown unknown no reference
GJE1 (Cx31.3) unknown unknown unknown no reference
GJC1 (Cx31.9) unknown unknown unknown no reference
GJB1 (Cx32) liver, oligodendrocytes,
chwann cells
Charot–Marie–Tooth disease liver carcinogenesis 302800
Cx32.4 unknown unknown unknown no reference
Cx36 neurons unknown visual defects no reference
GJA4 (Cx37) endothelium unknown female sterility no reference
GJA5 (Cx40) heart, endothelium unknown atrial arrhythmias no reference
Cx40.1 unknown unknown unknown
GJA1 (Cx43) heart, lens, brain,
adrenal gland, etc
oculodentodigital dysplasia,
ODDD
heart malformation 164200
GJA7 (Cx45) heart, smooth muscle,
neurons
unknown lethal no reference
GJA3 (Cx46) lens congenital cataracts, CZP3 nuclear-cataract 601885
GJA12 (Cx47) Spinal cord, brain unknown unknown no reference
GJA8 (Cx50) lens congenital cataracts, CZP1 microphthalmia,
pulverulent cataract
116200
GJA10 (Cx59) unknown unknown unknown no reference
Cx62 ovaries unknown unknown no reference
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[11,60,65] (OMIM 220290, 601544). It was also found
that pathological changes in the Cx26 sequence were
polymorphic and those patients with both syndromic and
nonsyndromic forms of deafness presented with a broad
spectrum of mutations within Cx26. In fact, several non-
sense and missense mutations within Cx26 have been
found in families with genetic deafness. Although there
is indisputable evidence linking Cx26 to genetic deafness,
there remain questions as to how mutations in the Cx26
gene generate the wide variety of pathological phenotypes
observed in patients with syndromic or nonsyndromic
forms of this disease.5. Cx26 function in the inner ear
Currently, the exact role of Cx26 in the onset of
nonsyndromic deafness remains unclear; however, it
appears that gap junctional communication influences the
ionic environment of the inner ear sensory epithelia. Of
particular interest is the fact that Cx26 is not expressed investibular hair cells, therefore mutant forms of Cx26 exert
their effects independent of the mechanical processes of
sound transduction. This observation is unique compared
to other forms of deafness that are brought on by abnor-
malities in genes that directly participate in the mechanics
of hearing, such as a-tectorin or myosin VIIA. [43,48,91]
(OMIM602574). Immunohistological studies involving co-
chlear-supporting cells that are coupled by gap junctions
have revealed a ubiquitous expression pattern for Cx26
[39,40]. Included within these cell populations are the
nonsensory epithelial cells that anchor the vestibular hair
cells, and the type II fibrocytes that form a layer of
connective tissue that lies distally to the epithelial cells
[41]. While the exact function of Cx26 within the cells of
the inner ear is unknown, it has been proposed that Cx26
plays a major role in the cycling of K+ ions during
auditory transduction. The mammalian cochlea is orga-
nized in a manner that segregates the extracellular envi-
ronment presented to the sensory fibers within this organ.
The basolateral surfaces of hair cells are surrounded by
perilymph, which has an ionic composition similar to that
of other extracellular fluid compartments. The apices of
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resembles intracellular fluids due to the high K+ and low
Na+ concentrations present in both environments. Auditory
signals (sound) stimulate the uptake of K+ ions from the
endolymph by hair cells, which in turn expel the K+ ions
into the interstitial space of the organ of Corti [34]. The
expelled K+ ions then pass into cochlear supporting cells
through channels specific for K+ ions [64]. It has been
hypothesized that gap junctional communication is respon-
sible for the recirculation of K+ ions from the cochlear
supporting cells back into the endolymph with gap junc-
tions providing an intercellular pathway for this cycling
mechanism.
Data supporting this hypothesis have emerged through
the generation of mice lacking cochlear connexins 26 and
30. Complete removal of the Cx26 gene results in neonatal
lethality, thereby preventing analysis of its function in
hearing [23]. This limitation was overcome through the
generation of a cochlear specific knockout of Cx26 using
the Cre–LoxP recombination system [14] successfully
deleting Cx26 in a subset of cochlear cells without effect-
ing Cx26 expression in other organs. Animals with this
deletion are a model of recessive deafness and displayed
normal patterns of cochlear development, but showed an
increase in postnatal cell death within the cochlea along
with significant hearing loss. The initiation of cell death
was found to occur near the inner hair cells, and coincided
with the onset of audition. It was hypothesized that loss of
Cx26 prevented recycling of K+ ions after sound stimula-
tion, and that elevated K+ in the extracellular perilymph
inhibited uptake of the neurotransmitter glutamate, which
ultimately resulted in cell death within the hair cell
population. While the evidence concerning Cx26 is com-
pelling, this hypothesis becomes more complex when
considering the activity of Cx30 in the inner ear. Lauter-
mann et al. [46] have shown that Cx26 and Cx30 normally
co-localize within the cochlea, and tissue-specific deletion
of the Cx26 gene did not alter expression patterns of Cx30
[14]. This observation complicates the role of gap junc-
tional communication in the recycling of K+ ions in the
onset of deafness due to the fact that Cx30 passes K+ ions
in an efficient manner [90] but could not prevent hearing
loss in the absence of Cx26; thus, the presence of a single
type of connexin with similar ionic selectivity was unable
to rescue the phenotype observed in these mice.
A second mouse model has examined the pathology of
dominant deafness mutations by transgenically expressing
a dominant negative Cx26 mutant, R75W [44]. This
missense mutation was originally characterized as causing
syndromic deafness associated with skin disease and its
dominant-negative effects were ascertained by using the
paired oocyte expression system, in which channel activity
was inhibited when expressed alone or when co-expressed
with wild-type Cx26 [75]. Expression of the R75W muta-
tion in mice resulted in profound deafness that was evident
as early as 2 weeks of age. Furthermore, mice carrying theR75W mutation presented with significant histological
abnormalities within the inner ear, which became more
severe over time. At 2 weeks of age, R75W mutant
animals displayed deformities of both the tunnel of Corti
and the supporting hair cells, whereas by week 7, both
structures had completely degenerated [44]. These findings
suggest that the R75W mutation in Cx26 exerts its effects
within the epithelial transport system of the inner ear by
altering the circulation of K+ ions into the cortilymph,
instead of the extracellular perilymph, as was reported in
the recessive Cx26 model [14]. This animal model also
suggests that diverse cochlear pathologies may arise
depending on the pattern of inheritance and/or the nature
of the Cx26 mutation.
Similar to the tissue-specific loss of Cx26, deletion of
Cx30 in mice resulted in hearing loss but did not alter
development of the inner ear [88]. Although development
was normal, Cx30 knockouts lacked the endocochlear
potential that normally results from the asymmetric Na+
and K+ concentrations in the endolymph and perilymph. In
addition, Cx30 knockouts also presented with increased
apoptosis within the cochlear sensory epithelium. Deletion
of Cx30 did not alter the cochlear expression of Cx26, again
raising the question of why the continued expression of
Cx26 was not able to compensate for the loss of Cx30 [88].
One possible explanation for these phenotypes is that gap
junctions may have other roles in addition to recycling K+
ions. This idea is supported by data from functional studies
showing that while the K+ conductances of Cx26 and Cx30
are similar, the channels display significant differences
regarding the permeability of fluorescent dyes that are
similar to cyclic nucleotides and second messengers in both
size and charge [7,54,90]. These findings indicate that
specific loss of either Cx26 or Cx30 within cochlear
epithelial cells would not simply reduce the intercellular
passage of K+ ions, but would also significantly alter the
availability of larger solutes that could be exchanged be-
tween the coupled cells.6. Cx26 and autosomal recessive deafness
Many studies have confirmed that mutations in Cx26
result in recessive deafness [10,19,21,36,47,103]. The most
common mutation associated with recessive deafness is a
single-base deletion (35delG) within the Cx26 gene. The
presence of the 35delG mutation in Cx26 raises several
interesting questions regarding its function in hearing loss.
First, it should be noted that the precise guanine residue
deleted cannot be determined as there are normally six
consecutive guanine residues from positions 30 to 35, and
an equivalent mutation has also been described as 30delG
in some studies [19,61]. Because this mutation appears to
be common in several ethnic backgrounds, researchers
have hypothesized that the six repeating guanine residues
may represent a ‘‘mutational hotspot’’ within the Cx26
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in persons with recessive deafness. Second, there appears
to be some diversity in the clinical phenotype of patients
that were homozygous for the 35delG mutation. In one
study, patients homozygous for the 35delG mutation were
described as having moderate hearing loss, whereas a
separate study involving compound heterozygotes and
patients homozygous for the 35delG presented with com-
plete deafness [19,30]. This variable phenotype may result
from genetic modifiers that act in concert with the Cx26
mutation to affect the deafness phenotype.
In addition to the 35delG mutation, there are other
mutations such as nonsense mutations, deletions and inser-
tions within the Cx26 gene that result in hearing loss. One
such mutation, M34T, has remained enigmatic in spite of
numerous studies of this allele. Initially, the M34T mutant
was characterized as an autosomal dominant mutation that
resulted in deafness [38]. This finding was supported by
functional data in which the M34T mutant exerted a
dominant-negative effect on wild-type Cx26 when co-
expressed [17,97]. However, these results were called into
question when it was found that many individuals hetero-
zygous for the M34T mutation retained normal hearing,
challenging the notion that M34T was a dominant mutation
[31,84]. Other in vitro studies detected defects in the
assembly and trafficking of the M34T mutant, as well as
reduced channel activity [55,89], which were incompatible
with the assertion that M34T may represent a mere poly-
morphism [84]. Further analysis of deaf patients revealed
that individuals homozygous for the M34T mutation pre-
sented with mild to high frequency hearing loss, and
compound heterozygotes of M34T with other mutant
Cx26 alleles such as 35delG were also deaf, suggesting
that M34T may be a recessive allele [33,36,104], although
some studies have hypothesized that the pathological effect
of the M34T allele was highly dependant on the nature of
the other Cx26 allele with which it was paired [16]. Early
attempts to explain these discrepancies between dominant
and recessive modes of action hypothesized that a second
site mutation may silence some of the M34T alleles [97,99].
Subsequently, it was found that majority of the M34T
alleles coincided with a 10-bp deletion in the 5V UTR of
Cx26 [33,104]. Whether this deletion is of any significance
remains unclear, but its association with the M34T mutation
may help to explain variability in the phenotypes of humans
carrying the M34T allele. Currently, the only point on
which there is apparent agreement is that the M34T muta-
tion is present at a high frequency [30,104], and further
research is needed to clarify its role in nonsyndromic
deafness.7. Cx26 and autosomal dominant deafness
While the importance of mutations in Cx26 is evident in
autosomal recessive nonsyndromic deafness, dysfunction inthe Cx26 gene also plays a role in the onset of dominant
forms of deafness (DFNA3). In one well-characterized
example, dominant nonsyndromic deafness was attributed
to a G-to-C transition that resulted in a tryptophan-to-
cysteine substitution at position 44 (W44C) in the Cx26
gene [18]. This mutation was detected in the 20 individuals
that exhibited hearing loss, but none of the subjects with
normal hearing. It was hypothesized that the additional
cysteine residue interfered with disulfide bond formation,
which in turn generated a dominant-negative effect on
neighboring connexins [18]. Functional analysis of this
mutant revealed the inability of W44C channels to allow
passage of the gap junction permeable dye Lucifer yellow
when expressed in HeLa cells [6]. When co-expressed with
wild-type Cx26, W44C mutants further altered channel
activity by reducing both the magnitude of the junctional
current, and the voltage dependence of wild-type Cx26
channels [6]. In contrast to the W44C data, a separate
recessive mutation, W77R, did not alter the activity or the
voltage dependence of wild-type Cx26 channels in this
study. Additional mutations within the Cx26 gene are also
responsible for the onset of dominant nonsyndromic deaf-
ness. One such mutation is a G-to-A transition, which
resulted in an arginine-to-glutamine substitution (R143Q).
This mutation was found to affect a highly conserved
residue within the third transmembrane domain of Cx26
[49]. Another Cx26 mutation involved in dominant forms of
deafness was found in the fourth transmembrane domain of
the Cx26 protein. This mutation resulted from a G-to-T
transition at nucleotide 605, which in turn generated a
cysteine-to-phenylalanine substitution (C202F). Subjects
with this mutation exhibited a later onset of hearing loss,
with effects becoming evident between 10 and 20 years of
age [62]. Taken together, these studies have established a
clear role for Cx26 mutations in dominant forms of non-
syndromic deafness.8. Connexin 26 and skin disease
Dominant mutations in Cx26 have also been described
in syndromic deafness associated with skin disease. These
hereditary skin diseases can be described as a number of
disorders with varying phenotypes, but similar genetic
abnormalities. These disorders include keratitis-ichthyo-
sis-deafness syndrome (KID), palmoplantar keratoderma
with deafness (PPK), Vohwinkel syndrome (VS), and
hystrix-like ichthyosis-deafness syndrome (HID) [37,73].
In spite of this range of hereditary skin disorders, there
are important genetic and phenotypic characteristics that
are common to each disease. Genetically, all of the skin
disorders mentioned can result from mutations in the
Cx26 gene, with the nature of each disease depending
on the particular mutation. With regards to phenotype,
skin disorders related to mutant forms of Cx26 show
great variability, but generally involve an increased thick-
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critical role for connexins in maintaining the balance
between proliferation and differentiation of the epidermis,
with severe consequences when this balance is offset by
mutant alleles of the Cx26 gene.
Although several different mutations have been identi-
fied, the exact role of Cx26 in skin disease cannot be
attributed to loss of Cx26 channel activity alone due to
the fact that many Cx26 mutations result in nonsyndromic
deafness. This would indicate that mutant forms of Cx26
associated with skin disorders must impact additional
genes in a manner that upsets tissue homeostasis and
results in disease. Since the skin expresses several other
connexins besides Cx26, these genes are good candidates
for the trans-pathological actions of mutant forms of
Cx26. Although this view has yet to be conclusively
proven, it is clear that that connexins can form hetero-
meric structures [94]; therefore, mixing of normal con-
nexin proteins with mutant forms of Cx26 may be the
underlying cause of skin disease associated with muta-
tions in the Cx26 gene. Consistent with this view, it was
shown that mutant forms of Cx26 acted as a trans-
dominant inhibitor of other connexin genes expressed in
the skin [79]. In this study, it was found that wild-type
Cx26 was able to form functional channels when co-
expressed with wild-type Cx43, but that mutant forms of
Cx26 that were associated with palmoplantar keratoderma
significantly reduced channel activity of wild-type Cx43,
thereby suggesting a trans-dominant effect of mutant
Cx26. As an elegant control, expression of a Cx26 allele
associated with nonsyndromic dominant deafness (W44C)
did not inhibit the activity of Cx43, showing that trans-
dominant inhibition of Cx43 was restricted to the syn-
dromic deafness mutants. Most importantly, it was shown
that one syndromic mutant allele of Cx26 (delE42) was
co-localized with Cx43 in suprabasal keratinocytes in
lesional skin from an affected patient, supporting the
hypothesis that these proteins interact in vivo at the site
of skin pathology [79]. Presumably, loss of function in
these two gap junction proteins impacts homeostasis by
preventing sharing of important nutrients and signaling
molecules that help maintain the proper proliferative
balance in the epidermis. These data support the hypoth-
esis that skin disease-associated Cx26 mutants alter the
function of other genes in addition to Cx26.9. Connexin function in the skin
Adult skin consists of two distinct tissues, the meso-
dermally derived dermis and the ectodermally derived
epidermis. The epidermis is primarily composed of kera-
tinocytes that are subdivided into four layers: the inner
most basal layer (stratum basale), the spinous layer
(stratum spinosum), the granular layer (stratum granulo-
sum), and the outermost cornified layer (stratum cor-neum). Cells in the basal layer continuously proliferate
and terminally differentiate as they push upward into the
spinous, granular and cornified layers, where they are
eventually shed. Maintaining a uniform epidermal thick-
ness requires tight regulation of keratinocyte growth and
differentiation, and it has been suggested that gap junc-
tion-mediated cell communication may play a role in this
regulation [8]. Ultrastructural analyses of human [9] and
rodent [76] epidermis have detected gap junctions be-
tween keratinocytes residing in the basal, spinous, and
granular layers, but not between cells in the cornified
layers. These results are consistent with Lucifer yellow
dye-transfer experiments that showed junctional commu-
nication between keratinocytes populating the three inner
epidermal layers of newborn mouse [35], adult mouse [1]
and adult human [81] skin. However, dye transfer experi-
ments suggested that the epidermal keratinocytes were
organized into small ‘‘communication compartments’’
consisting of 20–25 cells; dye transfer occurred between
basal and suprabasal keratinocytes within a compartment,
but was reduced between keratinocytes in neighboring
compartments. The epidermal communication compart-
ment was postulated to correlate with an epidermal
proliferative unit [70], consistent with a role for gap
junction-mediated cell communication in controlling ker-
atinocyte growth [35,68].
The molecular basis underlying the development and
maintenance of communication compartments in the epider-
mis is not known, but marked changes in connexin expres-
sion have been observed in human epidermis following
pathological or experimentally induced changes in kerati-
nocyte proliferation. In normal human skin, retinoic acid
treatment resulted in a thickening of the epidermis and an
increase in the number of keratinocytes, which were both
correlated with a massive induction of Cx26 expression in
all epidermal layers, and a somewhat smaller increase in
Cx43 levels. [57]. In human psoriatic lesions, a similar large
induction of Cx26 has been reported in the hyperprolifer-
ative psoriatic areas but not in the surrounding control
epidermis [45,77]. In experimentally wounded human skin,
up-regulation of Cx26 expression has also been observed,
and it temporally preceded increases in cell proliferation
[50]. In normal human interfollicular epidermis, Cx43 is
broadly expressed while Cx26 is not detected, except at low
levels in plantar epidermis [50,80]. Taken together, these
studies establish an intriguing correlation between increased
Cx26 expression and human keratinocyte proliferation and
differentiation.
Similar changes in connexin expression have been
reported in rodent epidermis undergoing changes in pro-
liferation. In one study examining connexin changes after
wounding, Cx26 expression rapidly increased in keratino-
cytes proximal to the wound, but was decreased in cells
at the wound edge proper. The increased expression of
Cx26 persisted in the hyperproliferative epidermis up to 6
days after wounding [25]. In another study of mouse skin
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elevated in the proliferating neoplasms, but not in sur-
rounding normal skin [83]. Thus, mouse epidermis
behaves very much like human epidermis with regard to
changes in connexin expression associated with hyper-
proliferation; namely, a large induction in Cx26 expres-
sion is consistently correlated with an increase in
keratinocyte numbers. This congruence between changes
in epidermal connexin expression and keratinocyte prolif-
eration in mice and humans supports the use of mice as
experimental models to study human skin pathologies that
arise from mutations in the Cx26 gene.
To date, only one mouse model of a human connexin
skin disorder has been described. Vohwinkel syndrome was
the first known skin disease to be attributed to mutations in
the Cx26 gene [53,75]. In one large pedigree with classic
Vohwinkel syndrome, affected patients were heterozygous
for the D66H mutation in the Cx26 gene [53]. Based on the
strong genetic evidence linking it to Vohwinkel syndrome,
D66H was subsequently used to generate transgenic mice
expressing the mutant under the control of a keratin pro-
moter in suprabasal epidermal keratinocytes [2]. Instead of
localizing at intercellular gap junctions, the transgenic
D66H accumulated in the keratinocyte cytoplasm. Consis-
tent with the model of trans-dominant effects of Cx26 skin
disease mutants described above, Cx30 was also redistrib-
uted into the cytoplasm from intercellular junctions in the
D66H transgenic animals. Early postnatal skin in the trans-
genic mice showed epidermal scaling with zonal hyperker-
atosis of the tail and digits producing constriction bands, a
hallmark feature of Vohwinkel syndrome. Microscopic
analysis revealed areas of hyperkeratosis and a thickened
stratum corneum associated with an increase in keratinocyte
apoptosis as well as increased proliferation in the lesional
areas. These results were consistent with the skin pathology
seen in human patients and suggested that the D66H
mutation caused premature keratinocyte death in the upper
epidermis, with compensatory hyperproliferation in the
basal layer, leading to a thickened stratum corneum.10. Connexins in the mammalian lens
Mutations within human connexin genes have also been
shown to produce cataracts [22,95], and research in this
genetic disorder has been greatly facilitated by the devel-
opment of numerous animal models where gap junction
proteins expressed in the mammalian lens have been
genetically manipulated [27,56,78,92,98,100]. Because of
its unique function and anatomy, the mammalian lens is
critically dependant on the proper functioning of gap
junction proteins. The anterior surface of the lens consists
of a simple cuboidal epithelium, while the rest of the
lenticular mass is composed of highly differentiated and
elongated fiber cells. The fiber cells are unusual in that
they lose their intracellular organelles while accumulatinghigh concentrations of soluble crystallin proteins that
increase their refractive index. The loss of intracellular
organelles presents the differentiated lens fiber cells with a
unique homeostatic challenge, as these cells cannot inde-
pendently support their own metabolism. Gap junctions
contribute to lens function by helping maintain an envi-
ronment that favors crystallin solubility and fiber transpar-
ency by coupling the metabolically active epithelium and
the organelle lacking lens fibers into a syncytium
[20,28,58,59]. Thus, connexin-mediated communication
allows the fibers to maintain transparency and prevent
light scattering so that images are properly focused onto
the retina. In support of this hypothesis, both Cx46 and
Cx50 knockout mice develop nuclear cataracts [27,98], but
the nature of the defects is different depending on which
connexin protein is deleted.11. Genetic knockout of lens connexins
The lens expresses three different connexins, Cx43,
Cx46, and Cx50, all of which appear to provide various
functions that contribute to maintaining lens homeostasis
[42,63,96]. Deletion of Cx43 results in neonatal lethality,
which prevents investigators from determining the long-
term effects of the loss of this protein in the lens; however,
prenatal ocular development was found to proceed normally
in the Cx43 knockout mice [100]. In contrast, deletion of
either Cx46 or Cx50 does not compromise viability and the
ocular phenotypes of these two animal models have been
well documented [27,78,98].
Deletion of Cx50 in mice results in two distinct lens
phenotypes, a mild nuclear cataract coupled with a signif-
icant ocular growth defect that includes both the eye and the
lens [78,98]. Although both phenotypes are present in Cx50
knockouts, it appears that Cx50 plays a major role in the
normal growth of the lens, with a relatively small role in
maintaining lens clarity. It is believed that the ocular growth
defect observed in Cx50 knock out mice results from a
reduction of lens growth, an idea that is supported by
previous studies showing a direct link between eye and lens
growth [15]. Recent data concerning the growth defect in
Cx50 knockouts show a significant retardation in lens cell
division during the first postnatal week [85]. While the
underlying factors governing the reduction in cell division
remain unclear, it is obvious that the reduced rate of cell
division contributes to the growth defect observed in these
mice. The onset of the cataract phenotype in Cx50 knock
out mice also occurs within the first postnatal week, and
results in a mild nuclear cataract that is characterized by the
precipitation of crystallin proteins [98] [78]. While the
precise mechanisms by which loss of Cx50 generates
crystallin precipitation are not known, it has recently been
reported that the severity of crystallin precipitation, but not
the growth defect, in Cx50 knockouts is under the influence
of an unidentified genetic modifier(s) [24]. Thus, the two
D.A. Gerido, T.W. White / Biochimica et Biophysica Acta 1662 (2004) 159–170166phenotypes are independent of each other, and the growth
defect is prominent in all mice with the Cx50 deletion,
whereas the cataract phenotype can be influenced by sec-
ondary mechanisms which, to date, have not been identified.
Additional data also revealed that the abnormalities ob-
served in these mice did not simply result from the loss of
intercellular communication. Data showing that expression
patterns of Cx46 were normal in Cx50 knockouts, and that
lenses from Cx50 knockouts were able pass gap junction
permeable ions and dyes, supported this finding [3,98].
Disruption of the Cx46 gene also produced cataracts;
however, the cataract phenotype was very different com-
pared to the Cx50 knockout animals. Deletion of Cx46
resulted in severe cataracts associated with precipitation of
several crystallin proteins and a specific proteolysis of g-
crystallins [27]. The severity of cataracts in these animals
was also found to be influenced by genetic modifiers and
cataract severity correlated well with the amount of cleaved
g-crystallin [26]. While both the Cx50 and the Cx46 knock-
outs display cataracts that are caused by crystallin precipi-
tation, specific cleavage of g-crystallins was unique to Cx46
knockout animals. Interestingly, Cx46 knockouts did notFig. 2. Comparison of wild-type and double knockout mice. Lenses from mice lac
surface (A), or on the equatorial edge (B). Disruption of both connexin genes re
anterior surface (C) and the equatorial edge (D). Opacities observed in double kn
alone, indicating a cumulative impact of connexins on lens transparency.display the growth defects observed in the Cx50 knockouts.
These data would argue that Cx46 has a central role in
maintaining lens clarity, but has no effect on postnatal
ocular growth. This hypothesis was supported by data
showing that targeted replacement of the Cx50-coding
region with the Cx46-coding region generated clear lenses
with a growth defect similar to that observed in Cx50
knockout animals [92]. Thus, diversity of connexin channels
was required for normal lens functioning, whereas the total
channel number was much less important.
Recently, double knockout mice lacking both the Cx46
and Cx50 genes have been generated (Xiahuoa Gong,
personal communication, Fig. 2). These animals presented
with a dense opacity that was far more extensive than that
observed in either the Cx46 or Cx50 single knockout mice.
Presumably, the increased density of the opacities in these
mice resulted from the total absence of gap junction proteins
in the lens fiber cells. Double knockout mice also displayed
a significant reduction in lens growth that was comparable
to that observed in single Cx50 knockout animals. The
presence of both the cataract and growth defect phenotypes
in the double knockout mice further confirms the impor-king both Cx50 and Cx46 were photographed looking down on the anterior
sulted in severe cataracts. Wild-type mice were also photographed on the
ockouts are far more severe than those seen in knockout of Cx50 or Cx46
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cially with regards to the maintaining crystallin solubility.12. Connexin mutations cause dominant cataracts in
humans
Cataracts are one of the leading causes of visual impair-
ment in humans. Early evidence described a congenital
zonular pulverulent human cataract (CZP1, OMIM116200)
that was later mapped to the long arm of human chromosome
1 which contains the Cx50 gene [13,72]. Further analysis of
congenital cataracts revealed that mutations within the Cx50
gene were responsible for the observed cataracts. One such
mutation is a C-to-T transition that resulted in the substitu-
tion of a serine residue at position 262 for a proline residue
[86]. This mutation was only detected in individuals with
cataracts in a large pedigree spanning several generations.
Subsequently, additional mutations within the Cx50 gene
were found to cause congenital cataracts. Like the P88S
mutation, the variants R23T, E48K, and I247M all encoded
single-amino-acid substitutions [5,32,69].
Mutations in the Cx46 gene have also been linked to
zonular pulverulent cataracts in humans (CZP 3 OMIM
601885). To date, three separate mutations have been
identified in the Cx46 gene that result in congenital cata-
racts. Two of these mutations are substitutions resulting in
asn63ser and pro187leu Cx46 mutants [52,71]. The third
mutation was identified as an insertion of a cytosine at
nucleotide position 1137 within the Cx46 gene [52]. While
there is a strong correlation between data linking cataracts to
connexins, it should be noted that there are distinct differ-
ences in the inheritance patterns seen in humans and the
knockout mice. Congenital cataracts in humans typically
follow an autosomal dominant pattern of inheritance, where-
as the phenotypes studied in knockout mice are recessive.
To date, recessive cataracts caused by connexin mutation
have not been described in humans, but dominant cataracts
have been identified in mice which carry point mutations in
Cx50 that resulted from treatment with chemical mutagens
[12] [87] [29]. The finding of dominant cataracts in mice
may provide researchers with additional animal models that
more closely resemble the cataract phenotypes seen in
humans.13. Conclusions
The importance of gap junctions has become increas-
ingly evident through the study of human disorders caused
by mutations in connexin genes. While studying gap
junction-mediated intercellular communication presents
unique challenges, the advent of suitable animal models
appears to aid the understanding of several connexin-
mediated disorders. There appears to be two important
aspects of gap junctional communication that are evidentin most connexin related disorders. One is the inability of
other gap junctions expressed in the same tissue to account
for loss of function in one particular gene. This lack of
redundancy increases the importance of each connexin, and
restricts the ability of cells to compensate for mutant forms
of these proteins. The second characteristic of connexin-
mediated diseases is the ability of mutant genes to alter the
activity of other genes expressed in the same tissue. This
may result from simply mixing the subunits from different
connexin genes, or may represent some other critical
processes that are influenced by gap junctions. This leaves
new and exciting challenges for future work in this field.
Perhaps the most daunting challenge remaining for
researchers will be understanding the downstream molecu-
lar events that ultimately bring about pathologies in persons
expressing mutant connexin isoforms.Acknowledgements
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